{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Claims that Drug Manufacturer Paid PBMs to Disrupt Operation of State Generic Substitution Laws not Viable, Says Illinois Court",
"url": "https://www.floridaipblog.com/archives/connection-check-4agyu0xa/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-NSF8QFDG",
"url": "https://www.lexblog.com/lib/NSF8QFDG/"
},
"datePublished": "2025-07-17T09:04:51-04:00",
"dateModified": "2025-11-14T11:20:20-05:00",
"author": {
"@type": "Person",
"name": "Brandon Gould"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Covington & Burling LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Inside Class Actions",
"about": "Antitrust, Competition and Trade ยท Banking, Finance and Securities",
"sourceUrl": "https://www.insideclassactions.com/?p=12813",
"sourceStability": "may-move"
}